Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Elmiron Lawsuits Being Filed Against Drug Companies for Elmiron-Related Eye Problems

September 4, 2020 By Law Offices of Thomas J. Lamb, P.A.

Elmiron lawsuits are being filed by patients who have experienced eye problems due to Elmiron, which is a bladder disease treatment medicine. In recent years there have been reports of patients who used Elmiron developing vision loss due to Elmiron-related maculopathy. But there were not any warnings about these Elmiron eye problems in the Elmiron Prescribing Information document, or drug label, until June 2020.

Remarkably, prior to that time, despite reports of Elmiron-related maculopathy, the Prescribing Information for Elmiron in the US simply stated “Warnings: None”.

The June 2020 Elmiron label change which finally added warnings concerning vision problems such as retinal pigmentary changes and pigmentary maculopathy was overdue from our perspective. Accordingly, there have been Elmiron lawsuits filed by patients who have eye problems due to Elmiron against the pharmaceutical companies responsible for Elmiron.

The growing number of Elmiron lawsuits filed by patients usually contain these types of legal claims alleged against the drug companies: Strict Liability / Negligence / Misrepresentation / Breach of Warranty.

We are currently investigating possible Elmiron lawsuits for patients who have been diagnosed with eye problems due to Elmiron, such as retinal maculopathy, pigmentary maculopathy, and macular degeneration.

It is important for patients who used Elmiron to know that maculopathy — which is a degeneration of the central part of the retina — can have a range of symptoms, including:

• Central vision loss
• Blurred, dimmed, or spotty vision
• Difficulty reading
• Difficulty adjusting to low light or changes in lighting
• Pain in the eye

Significantly, a person does not need to be using Elmiron up until the time when their Elmiron-related eye problem was diagnosed to be in a position to file an Elmiron lawsuit (unlike most other drug injury cases).

Please feel free to contact us if we can be of assistance as regards a possible Elmiron lawsuit.

[View article at original source]

Elmiron

Free Case Evaluation

Strictly Confidential, No Obligation

Filed Under: Unsafe Drugs Tagged With: Elmiron, macular degeneration, maculopathy, pigmentary maculopathy, retinal maculopathy, vision loss

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.